EAM Investors, LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 121 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$3,036,000
+69.1%
89,585
+5.7%
0.54%
+127.6%
Q3 2017$1,795,000
-55.2%
84,793
-40.1%
0.24%
-54.4%
Q4 2015$4,006,000
+227.6%
141,448
+203.2%
0.52%
+266.4%
Q2 2015$1,223,00046,6550.14%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
C Partners Holding GmbH 1,662,128$29,037,0009.28%
GREAT POINT PARTNERS LLC 608,650$10,645,0004.68%
Opaleye Management Inc. 255,000$4,460,0002.07%
EMERALD MUTUAL FUND ADVISERS TRUST 326,530$5,721,0000.47%
Granite Point Capital Management, L.P. 61,813$1,076,0000.39%
WALL STREET ASSOCIATES 225,000$3,935,0000.37%
EMERALD ADVISERS, LLC 322,631$5,652,0000.28%
Spark Investment Management LLC 75,500$1,317,0000.18%
TFS CAPITAL LLC 98,443$1,722,0000.17%
PRIVATE ASSET MANAGEMENT INC 47,690$834,0000.14%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders